These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25387182)

  • 1. Overcoming the reimbursement barriers for clinical sequencing.
    Deverka PA; Kaufman D; McGuire AL
    JAMA; 2014 Nov; 312(18):1857-8. PubMed ID: 25387182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is NGS already in clinical use?].
    Jordan B
    Med Sci (Paris); 2011 Dec; 27(12):1127-30. PubMed ID: 22192753
    [No Abstract]   [Full Text] [Related]  

  • 3. Illumina claims $1,000 genome win.
    Sheridan C
    Nat Biotechnol; 2014 Feb; 32(2):115. PubMed ID: 24509738
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole genome sequencing: a considered approach to clinical implementation.
    Dimmock D
    Curr Protoc Hum Genet; 2013; Chapter 9():Unit9.22. PubMed ID: 23595600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
    Trosman JR; Weldon CB; Gradishar WJ; Benson AB; Cristofanilli M; Kurian AW; Ford JM; Balch A; Watkins J; Phillips KA
    Value Health; 2018 Sep; 21(9):1062-1068. PubMed ID: 30224110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic testing: the clinical laboratory perspective.
    Faruki H
    Clin Pharmacol Ther; 2013 Aug; 94(2):190-2. PubMed ID: 23872833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling in oncology.
    Buchanan AH; Stopfer JE
    JAMA; 2011 Oct; 306(13):1442; author reply 1442-3. PubMed ID: 21972303
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical integration of next generation sequencing: coverage and reimbursement challenges.
    Deverka PA; Dreyfus JC
    J Law Med Ethics; 2014; 42 Suppl 1(Suppl 1):22-41. PubMed ID: 25298289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
    Trosman JR; Weldon CB; Douglas MP; Kurian AW; Kelley RK; Deverka PA; Phillips KA
    J Natl Compr Canc Netw; 2017 Feb; 15(2):219-228. PubMed ID: 28188191
    [No Abstract]   [Full Text] [Related]  

  • 10. Single Genes, Panels, and Next-Generation Sequencing Platforms: A Financial Perspective.
    Sireci AN
    Arch Pathol Lab Med; 2018 Jul; 142(7):790-791. PubMed ID: 29595318
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer gene sequencing: ethical challenges and promises.
    Devarakonda S; Govindan R; Hammerman PS
    Virtual Mentor; 2012 Nov; 14(11):868-72. PubMed ID: 23351899
    [No Abstract]   [Full Text] [Related]  

  • 12. Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation.
    Phillips KA; Douglas MP; Marshall DA
    JAMA; 2020 Nov; 324(20):2029-2030. PubMed ID: 33104159
    [No Abstract]   [Full Text] [Related]  

  • 13. Next generation sequencing is here now.
    Erickson RP
    Lymphology; 2014 Dec; 47(4):196-7. PubMed ID: 25915980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA-approved Next-Generation sequencing system could expand clinical genomic testing: experts predict MiSeqDx system will make genetic testing more affordable for smaller labs.
    Am J Med Genet A; 2014 Mar; 164A(3):x-xi. PubMed ID: 24591037
    [No Abstract]   [Full Text] [Related]  

  • 16. As genetic tests move into the mainstream, challenges await for doctors and patients.
    Zielinski SL
    J Natl Cancer Inst; 2005 Mar; 97(5):334-6. PubMed ID: 15741567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sequencing babies?].
    Jordan B
    Med Sci (Paris); 2015 Oct; 31(10):929-32. PubMed ID: 26481033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reimbursement decision-making in Thailand, China, and South Korea.
    Ngorsuraches S; Meng W; Kim BY; Kulsomboon V
    Value Health; 2012; 15(1 Suppl):S120-5. PubMed ID: 22265058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation--promiscuity in the era of next-generation sequencing.
    Lu JT; Campeau PM; Lee BH
    N Engl J Med; 2014 Aug; 371(7):593-6. PubMed ID: 25119605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health risks, heredity screening and insurance].
    Arnold IJ; van de Vathorst S
    Ned Tijdschr Geneeskd; 1991 Mar; 135(11):480-3. PubMed ID: 2023656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.